Related Experiment Video
Updated: Jun 22, 2025

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
Published on: August 14, 2018
TP53 mutations correlate with the non-coding RNA content of small extracellular vesicles in melanoma
Maureen Labbé1, Estelle Menoret1,2, Franck Letourneur3
1Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers CRCI2NA Nantes France.
Abstract:
Non-coding RNAs (ncRNAs) are important regulators of gene expression. They are expressed not only in cells, but also in cell-derived extracellular vesicles (EVs). The mechanisms controlling their loading and sorting remain poorly understood. Here, we investigated the impact of TP53 mutations on the non-coding RNA content of small melanoma EVs. After purification of small EVs from six different patient-derived melanoma cell lines, we characterized them by small RNA sequencing and lncRNA microarray analysis. We found that TP53 mutations are associated with a specific micro and long non-coding RNA content in small EVs. Then, we showed that long and small non-coding RNAs enriched in TP53 mutant small EVs share a common sequence motif, highly similar to the RNA-binding motif of Sam68, a protein interacting with hnRNP proteins. This protein thus may be an interesting partner of p53, involved in the expression and loading of the ncRNAs. To conclude, our data support the existence of cellular mechanisms associate with TP53 mutations which control the ncRNA content of small EVs in melanoma.
Insights
TP53 mutations alter non-coding RNA (ncRNA) profiles in melanoma extracellular vesicles (EVs). These mutated EVs contain specific ncRNAs with a sequence motif suggesting a role for Sam68 in their sorting.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Non-coding RNAs (ncRNAs) regulate gene expression within cells and are also found in extracellular vesicles (EVs).
- The mechanisms governing ncRNA loading and sorting into EVs are not fully understood.
- The tumor suppressor protein p53, encoded by the TP53 gene, plays a critical role in cancer development and progression.
Purpose of the Study:
- To investigate the impact of TP53 mutations on the non-coding RNA content of small EVs derived from melanoma cells.
- To identify specific ncRNAs affected by TP53 mutations in melanoma EVs.
- To explore potential mechanisms underlying the altered ncRNA profiles in TP53-mutated melanoma EVs.
Main Methods:
- Purification of small EVs from six patient-derived melanoma cell lines.
- Characterization of EV non-coding RNA content using small RNA sequencing and lncRNA microarray analysis.
- Bioinformatic analysis to identify sequence motifs and potential protein interactions.
Main Results:
- TP53 mutations were associated with a distinct profile of micro and long non-coding RNAs within small EVs.
- Enriched ncRNAs in TP53-mutant EVs shared a common sequence motif similar to the RNA-binding motif of Sam68.
- Sam68, a protein known to interact with hnRNP proteins, may be involved in the sorting of these ncRNAs.
Conclusions:
- TP53 mutations influence the specific non-coding RNA composition of small extracellular vesicles in melanoma.
- A shared sequence motif in ncRNAs suggests a potential role for Sam68 in mediating the effects of TP53 mutations on EV content.
- These findings indicate the existence of TP53 mutation-associated cellular mechanisms that control ncRNA loading into melanoma EVs.
Related Concept Videos
Abnormal Proliferation
Non-LTR Retrotransposons
MicroRNAs
The Nucleolus
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

